case_images: PMC11342423_01
case_images: Back and dorsal aspect of proximal lower extremity. Left: Patient 28 months into refractory disease course. Right: Patient 38 weeks after initial loading dose of dupilumab.
case_images: 10.1177_2050313X241274855-fig1.jpg
case_images: PMC11342423_01_10.1177_2050313X241274855-fig1.jpg
case_images: fig1-2050313X241274855
case_images: On physical examination, she had urticarial plaques and tense bullae on the inner aspect of her arms bilaterally, inner thighs, trunk, and back covering approximately 70% of her body surface area (Figures 1-3). In follow-up in February and April 2024, several well-circumcised round patches of post-inflammatory hyperpigmentation scattered across her entire body and a few erythematous papules were observed on her arms (Figures 1-4).
case_images: Ventral aspect of the lower extremities. Left: Patient 28 months into refractory disease course. Right: Patient 38 weeks after initial loading dose of dupilumab.
case_images: 10.1177_2050313X241274855-fig2.jpg
case_images: PMC11342423_01_10.1177_2050313X241274855-fig2.jpg
case_images: fig2-2050313X241274855
case_images: On physical examination, she had urticarial plaques and tense bullae on the inner aspect of her arms bilaterally, inner thighs, trunk, and back covering approximately 70% of her body surface area (Figures 1-3). In follow-up in February and April 2024, several well-circumcised round patches of post-inflammatory hyperpigmentation scattered across her entire body and a few erythematous papules were observed on her arms (Figures 1-4).
case_images: Ventral and right side of the body. Patient 28 months into refractory disease course.
case_images: 10.1177_2050313X241274855-fig3.jpg
case_images: PMC11342423_01_10.1177_2050313X241274855-fig3.jpg
case_images: fig3-2050313X241274855
case_images: On physical examination, she had urticarial plaques and tense bullae on the inner aspect of her arms bilaterally, inner thighs, trunk, and back covering approximately 70% of her body surface area (Figures 1-3). In follow-up in February and April 2024, several well-circumcised round patches of post-inflammatory hyperpigmentation scattered across her entire body and a few erythematous papules were observed on her arms (Figures 1-4).
case_images: Volar aspect of distal upper extremities. Patient after 38 weeks after the initial loading dose of dupilumab.
case_images: 10.1177_2050313X241274855-fig4.jpg
case_images: PMC11342423_01_10.1177_2050313X241274855-fig4.jpg
case_images: fig4-2050313X241274855
case_images: In follow-up in February and April 2024, several well-circumcised round patches of post-inflammatory hyperpigmentation scattered across her entire body and a few erythematous papules were observed on her arms (Figures 1-4).